Current and emerging pharmaceutical interventions for myopia
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2018-313798
Abstract: Myopia is a major cause of visual impairment. Its prevalence is growing steadily, especially in East Asia. Despite the immense disease and economic burden, there are currently no Food and Drug Administration-approved drugs for myopia.… read more here.
Keywords: interventions myopia; current emerging; ophthalmology; emerging pharmaceutical ... See more keywords